Stay updated on Pembrolizumab in Advanced Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Sarcomas Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision: v3.4.3 applied, replacing v3.4.2.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now shows a minor version update: v3.4.2 added and v3.4.1 removed, with no changes to study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe University of Texas MD Anderson Cancer Center is renamed to M.D. Anderson Cancer Center in the locations list, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page now includes a glossary display option, a new 'Last Update Submitted that Met QC Criteria' label, and a revision indicator (Revision: v3.4.0), while previous wording variants for QC status and FEAR Act data were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check84 days agoChange DetectedThe page shows a technical revision update from v3.3.3 to v3.3.4 without changes to study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.